Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome
- PMID: 2059078
- PMCID: PMC1004434
- DOI: 10.1136/ard.50.6.351
Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome
Abstract
Epidemiological data, family history, clinical data, and HLA typing were studied in three groups of patients with Behçet's syndrome: six Israeli Ashkenazi Jews, 29 non-Ashkenazi Jews, and three Israeli Arabs. HLA-B51 and B52 were present in 24/38 (63%) and 8/38 (21%), respectively, of the patients compared with 13/151 (9%) of the control group for both cases, a relative risk of 18.2 and 2.8 respectively. The syndrome was found in six of the 34 families. Ninety five per cent of the affected family members were either B51 or B52 positive. Eleven of the 14 families (79%) chosen for study contained a close relative of the proband who had recurrent oral ulcers. All the relatives with ulcers, except for one, were B51 or B52 carriers. Recurrent oral ulcers in the patients with Behçet's syndrome began a few years before other manifestations of the syndrome occurred. Our findings suggest that (a) HLA-B51 and HLA-B52 are primarily associated with Behçet's disease of Israeli patients; (b) the familial occurrence of this syndrome is high and occurs predominantly in the B5 positive group; (c) recurrent oral ulcers may be the first symptom of Behçet's syndrome, appearing early in life; HLA analysis can provide the clue for a correct diagnosis; (d) ulcer recurrence is common among members of a family containing a patient with Behçet's syndrome.
Similar articles
-
Association of the MIC-A gene and HLA-B51 with Behçet's disease in Arabs and non-Ashkenazi Jews in Israel.Ann Rheum Dis. 2002 Feb;61(2):157-60. doi: 10.1136/ard.61.2.157. Ann Rheum Dis. 2002. PMID: 11796403 Free PMC article.
-
HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet's syndrome.Am J Med. 1987 Oct;83(4):666-72. doi: 10.1016/0002-9343(87)90896-5. Am J Med. 1987. PMID: 3314492
-
Allelic distribution of HLA-B*5 in HLA-B5-positive Israeli patients with Behçet's disease.Tissue Antigens. 2001 Sep;58(3):185-6. doi: 10.1034/j.1399-0039.2001.580307.x. Tissue Antigens. 2001. PMID: 11703827
-
Familial Behçet's disease.Eur J Med. 1992 Nov;1(7):391-5. Eur J Med. 1992. PMID: 1341477 Review.
-
Relationships of HLA-B51 or B5 genotype with Behcet's disease clinical characteristics: systematic review and meta-analyses of observational studies.Rheumatology (Oxford). 2012 May;51(5):887-900. doi: 10.1093/rheumatology/ker428. Epub 2012 Jan 11. Rheumatology (Oxford). 2012. PMID: 22240504
Cited by
-
Characterization of the major histocompatibility complex locus association with Behçet's disease in Iran.Arthritis Res Ther. 2015 Mar 19;17(1):81. doi: 10.1186/s13075-015-0585-6. Arthritis Res Ther. 2015. PMID: 25889189 Free PMC article.
-
Autoimmune sensorineural hearing loss as presenting manifestation of paediatric Behçet disease responding to adalimumab: a case report.Ital J Pediatr. 2016 Sep 6;42(1):81. doi: 10.1186/s13052-016-0291-2. Ital J Pediatr. 2016. PMID: 27600159 Free PMC article.
-
Primary association of HLA-B51 with Behçet's disease in Ireland.Br J Ophthalmol. 1997 Aug;81(8):649-53. doi: 10.1136/bjo.81.8.649. Br J Ophthalmol. 1997. PMID: 9349151 Free PMC article.
-
Role of Human Leukocyte Antigens (HLA) in Autoimmune Diseases.Rheumatol Ther. 2018 Jun;5(1):5-20. doi: 10.1007/s40744-018-0100-z. Epub 2018 Mar 7. Rheumatol Ther. 2018. PMID: 29516402 Free PMC article. Review.
-
HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies.Arthritis Rheum. 2009 Oct 15;61(10):1287-96. doi: 10.1002/art.24642. Arthritis Rheum. 2009. PMID: 19790126 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials